Gain Capital Stock from 2010 to 2024

GANX Stock

USD 1.86 0.12 6.90%

Gain Therapeutics Capital Stock yearly trend continues to be fairly stable with very little volatility. Capital Stock will likely drop to 1,143 in 2024. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

1.6 K

Current Value

1.1 K

Quarterly Volatility

452.29231034

Credit Downgrade

Yuan Drop

Covid

Check Gain Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Gain Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 150 K, Net Interest Income of 579.3 K or Depreciation And Amortization of 44.3 K, as well as many indicators such as Price To Sales Ratio of 733, Dividend Yield of 0.0 or PTB Ratio of 3.55. Gain financial statements analysis is a perfect complement when working with Gain Therapeutics Valuation or Volatility modules.

Check out the analysis of Gain Therapeutics Correlation against competitors.

For more information on how to buy Gain Stock please use our How to Invest in Gain Therapeutics guide.

Latest Gain Therapeutics' Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Gain Therapeutics over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Gain Therapeutics' Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Gain Therapeutics' overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

Gain Capital Stock Regression Statistics

	Arithmetic Mean	617.09
	Geometric Mean	498.52
	Coefficient Of Variation	73.29
	Mean Deviation	390.79
	Median	324.00
	Standard Deviation	452.29
	Sample Variance	204,568
	Range	1.3K
	R-Value	0.81
	Mean Square Error	75,576
	R-Squared	0.66
	Significance	0.0002
	Slope	81.97
	Total Sum of Squares	2.9M

Gain Capital Stock History

	2024	1143.34
	2023	1621.0
	2021	1189.0
	2020	874.0

Other Fundumenentals of Gain Therapeutics

Issuance Of Capital Stock

Gain Therapeutics Capital Stock component correlations

	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Total Current Assets	Common Stock	Property Plant Equipment	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Total Liab	Net Invested Capital	Capital Stock	Net Working Capital	Short Term Debt	Long Term Debt	Short Long Term Debt	Intangible Assets	Long Term Debt Total	Capital Surpluse
Net Tangible Assets		-0.72	0.71	0.67	0.99	0.91	0.48	0.98	0.97	0.22	-0.92	0.87	0.97	0.89	0.97	0.99	-0.77	0.91	-0.16	-0.34	-0.34
Retained Earnings	-0.72		-0.82	-0.97	-0.67	-0.9	0.2	-0.71	-0.65	-0.71	0.49	-0.91	-0.66	-0.91	-0.65	-0.74	0.99	-0.92	0.58	0.81	0.81
Accounts Payable	0.71	-0.82		0.7	0.68	0.85	-0.1	0.71	0.65	0.26	-0.42	0.94	0.66	0.9	0.63	0.67	-0.83	0.82	-0.15	-0.43	-0.43
Net Receivables	0.67	-0.97	0.7		0.63	0.83	-0.14	0.66	0.61	0.83	-0.52	0.84	0.62	0.86	0.61	0.7	-0.93	0.85	-0.73	-0.9	-0.9
Total Current Assets	0.99	-0.67	0.68	0.63		0.86	0.53	1.0	1.0	0.16	-0.94	0.83	1.0	0.85	0.99	0.99	-0.73	0.88	-0.17	-0.32	-0.32
Common Stock	0.91	-0.9	0.85	0.83	0.86		0.11	0.87	0.83	0.44	-0.71	0.96	0.83	0.97	0.82	0.9	-0.92	0.98	-0.25	-0.51	-0.51
Property Plant Equipment	0.48	0.2	-0.1	-0.14	0.53	0.11		0.48	0.53	-0.34	-0.73	0.07	0.53	0.13	0.56	0.45	0.16	0.08	0.2	0.31	0.31
Total Assets	0.98	-0.71	0.71	0.66	1.0	0.87	0.48		1.0	0.19	-0.92	0.85	1.0	0.87	0.99	0.99	-0.77	0.9	-0.22	-0.38	-0.38
Total Stockholder Equity	0.97	-0.65	0.65	0.61	1.0	0.83	0.53	1.0		0.14	-0.94	0.8	1.0	0.82	1.0	0.98	-0.72	0.86	-0.2	-0.33	-0.33
Current Deferred Revenue	0.22	-0.71	0.26	0.83	0.16	0.44	-0.34	0.19	0.14		-0.16	0.43	0.15	0.48	0.16	0.28	-0.62	0.45	-0.86	-0.91	-0.91
Net Debt	-0.92	0.49	-0.42	-0.52	-0.94	-0.71	-0.73	-0.92	-0.94	-0.16		-0.65	-0.94	-0.7	-0.96	-0.93	0.54	-0.72	0.21	0.26	0.26
Total Liab	0.87	-0.91	0.94	0.84	0.83	0.96	0.07	0.85	0.8	0.43	-0.65		0.81	0.99	0.8	0.85	-0.92	0.94	-0.3	-0.56	-0.56
Net Invested Capital	0.97	-0.66	0.66	0.62	1.0	0.83	0.53	1.0	1.0	0.15	-0.94	0.81		0.83	1.0	0.98	-0.73	0.87	-0.2	-0.34	-0.34
Capital Stock	0.89	-0.91	0.9	0.86	0.85	0.97	0.13	0.87	0.82	0.48	-0.7	0.99	0.83		0.82	0.87	-0.91	0.94	-0.34	-0.58	-0.58
Net Working Capital	0.97	-0.65	0.63	0.61	0.99	0.82	0.56	0.99	1.0	0.16	-0.96	0.8	1.0	0.82		0.98	-0.71	0.85	-0.21	-0.34	-0.34
Short Term Debt	0.99	-0.74	0.67	0.7	0.99	0.9	0.45	0.99	0.98	0.28	-0.93	0.85	0.98	0.87	0.98		-0.8	0.92	-0.26	-0.42	-0.42
Long Term Debt	-0.77	0.99	-0.83	-0.93	-0.73	-0.92	0.16	-0.77	-0.72	-0.62	0.54	-0.92	-0.73	-0.91	-0.71	-0.8		-0.96	0.51	0.75	0.75
Short Long Term Debt	0.91	-0.92	0.82	0.85	0.88	0.98	0.08	0.9	0.86	0.45	-0.72	0.94	0.87	0.94	0.85	0.92	-0.96		-0.34	-0.58	-0.58
Intangible Assets	-0.16	0.58	-0.15	-0.73	-0.17	-0.25	0.2	-0.22	-0.2	-0.86	0.21	-0.3	-0.2	-0.34	-0.21	-0.26	0.51	-0.34		0.94	0.94
Long Term Debt Total	-0.34	0.81	-0.43	-0.9	-0.32	-0.51	0.31	-0.38	-0.33	-0.91	0.26	-0.56	-0.34	-0.58	-0.34	-0.42	0.75	-0.58	0.94		1.0
Capital Surpluse	-0.34	0.81	-0.43	-0.9	-0.32	-0.51	0.31	-0.38	-0.33	-0.91	0.26	-0.56	-0.34	-0.58	-0.34	-0.42	0.75	-0.58	0.94	1.0

Click cells to compare fundamentals

About Gain Therapeutics Financial Statements

Gain Therapeutics investors use historical fundamental indicators, such as Gain Therapeutics' Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Gain Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Capital Stock	1.6 K	1.1 K
Issuance Of Capital Stock	3.1 M	3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Gain Stock Analysis

When running Gain Therapeutics' price analysis, check to measure Gain Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gain Therapeutics is operating at the current time. Most of Gain Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gain Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gain Therapeutics' price. Additionally, you may evaluate how the addition of Gain Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Gain Capital Stock from 2010 to 2024

Latest Gain Therapeutics' Capital Stock Growth Pattern

Gain Capital Stock Regression Statistics

Gain Capital Stock History

Other Fundumenentals of Gain Therapeutics

Gain Therapeutics Capital Stock component correlations

About Gain Therapeutics Financial Statements

Also Currently Popular

Additional Tools for Gain Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY